Literature DB >> 1337336

Effects of cell differentiation on the synthesis of the third and fourth component of complement (C3, C4) by the human monocytic cell line U937.

H Tsukamoto1, K Nagasawa, Y Ueda, T Mayumi, I Furugo, T Tsuru, Y Niho.   

Abstract

Association of complement synthesis with cell differentiation in U937 cells was investigated using granulocyte-macrophage colony-stimulating factor (GM-CSF), vitamin D3 and interferon-gamma (IFN-gamma) as differentiation-inducing agents. GM-CSF or vitamin D3 enhanced the synthesis of the third component of complement (C3) by U937 cells, but had no stimulatory effect on the synthesis of the fourth component of complement (C4). IFN-gamma increased both C3 and C4 synthesis by U937 cells. Combination of two of these three agents resulted in synergistic enhancement and all three agents caused maximal enhancement of C3 synthesis. Vitamin D3 enhanced IFN-gamma-induced C4 synthesis by U937 cells. These results were confirmed by ELISA and SDS-PAGE after biosynthetic labelling. GM-CSF, vitamin D3 or IFN-gamma increased the expression of complement receptor type 3 (CR3), one of the markers of monocyte/macrophage differentiation. Two of these agents caused a further increase and all three agents maximal increase in CR3 expression. Since C3 was synthesized in parallel with the degree of CR3 expression, the synthesis of C3, but not C4, by U937 cells is thought to be closely related to cell differentiation. It was reconfirmed that the synthesis of C3 and C4 by U937 cells was independently regulated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1337336      PMCID: PMC1421655     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Synthesis and regulation of the fourth component of complement (C4) in the human monocytic cell line U937: comparison with that of the third component of complement (C3).

Authors:  H Tsukamoto; K Nagasawa; S Yoshizawa; Y Tada; A Ueda; Y Ueda; Y Niho
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

2.  In vitro biosynthesis of complement protein D by U937 cells.

Authors:  S R Barnum; J E Volanakis
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

3.  Increased production of the third component of complement (C3) by monocytes from patients with systemic lupus erythematosus.

Authors:  H Tsukamoto; A Ueda; K Nagasawa; Y Tada; Y Niho
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

4.  Establishment and characterization of a human histiocytic lymphoma cell line (U-937).

Authors:  C Sundström; K Nilsson
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

5.  High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells.

Authors:  J C Gasson; S E Kaufman; R H Weisbart; M Tomonaga; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

6.  Expression of complement factor H on the cell surface of the human monocytic cell line U937.

Authors:  V Malhotra; R B Sim
Journal:  Eur J Immunol       Date:  1985-09       Impact factor: 5.532

7.  Lymphokine and phorbol (PMA) regulation of complement (C2) synthesis using U937.

Authors:  B H Littman; R E Hall; A V Muchmore
Journal:  Cell Immunol       Date:  1983-02-15       Impact factor: 4.868

8.  Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol.

Authors:  I Olsson; U Gullberg; I Ivhed; K Nilsson
Journal:  Cancer Res       Date:  1983-12       Impact factor: 12.701

9.  Up-regulation of gamma interferon receptors on the human monocytic cell line U937 by 1,25-dihydroxyvitamin D3 and granulocyte-macrophage colony stimulating factor.

Authors:  S H Zuckerman; R D Schreiber
Journal:  J Leukoc Biol       Date:  1988-09       Impact factor: 4.962

10.  A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule.

Authors:  F Sanchez-Madrid; J A Nagy; E Robbins; P Simon; T A Springer
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  3 in total

1.  New aspects in the synthesis and secretion of lysozyme by cultured human monocyte cell lines.

Authors:  Racha Helal; Matthias F Melzig
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-21       Impact factor: 2.416

Review 2.  The biology of human lymphoid malignancies revealed by gene expression profiling.

Authors:  Louis M Staudt; Sandeep Dave
Journal:  Adv Immunol       Date:  2005       Impact factor: 3.543

Review 3.  On the Functional Overlap between Complement and Anti-Microbial Peptides.

Authors:  Jana Zimmer; James Hobkirk; Fatima Mohamed; Michael J Browning; Cordula M Stover
Journal:  Front Immunol       Date:  2015-01-19       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.